Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

281

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Rimonabant (SR141716)

Trial Locations (7)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY